Global Pharmacovigilance and Drug Safety Software Market Insights and Forecast to 2028

Pharmacovigilance and Drug Safety Software Market

The global Pharmacovigilance and Drug Safety Software market size is projected to reach USD 171.5 Million by 2028, from USD 116.7 Million in 2021, at a CAGR of 5.2% during 2022-2028.

Fully considering the economic change by this health crisis, Adverse Event Reporting Software accounting for % of the Pharmacovigilance and Drug Safety Software global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Pharma and Biotech Companies segment is altered to an % CAGR throughout this forecast period.

China Pharmacovigilance and Drug Safety Software market size is valued at US$ million in 2021, while the North America and Europe Pharmacovigilance and Drug Safety Software are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Pharmacovigilance and Drug Safety Software landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacovigilance and Drug Safety Software market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacovigilance and Drug Safety Software market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacovigilance and Drug Safety Software market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacovigilance and Drug Safety Software market.

Pharmacovigilance and Drug Safety Software market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pharmacovigilance and Drug Safety Software market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type

• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software

By Application

• Pharma and Biotech Companies
• Contract Research Organizations (CROs)
• Business Process Outsourcing (BPO) Firms
• Pharmacovigilance Service Providers
• Others

By Company

• AB Cube
• Sparta Systems, Inc.
• Oracle Corporation
• EXTEDO GmbH
• Ennov Solutions, Inc.
• ArisGlobal
• Oracle Corporation
• United BioSource Corporation
• Online Business Applications, Inc.
• UMBRA Global LLC

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Scope of Pharmacovigilance and Drug Safety Software Market Report